The Science Behind Treating sAML

Secondary AML (sAML) is not a one-size-fits-all diagnosis. Like a fingerprint, your experience with sAML is unique. This cancer is more common in older people who are more likely to have preexisting health conditions.1 It is considered difficult to treat and often requires specialized treatment.1,2

What to Know about Secondary AML

A diagnosis of secondary acute myeloid leukemia (sAML) can be overwhelming. Here are the basics about sAML that are important to understand.

sAML Subtype Testing: What to Know

There are several different types of acute myeloid leukemia (AML), including secondary AML (sAML).3 If you’ve been recently diagnosed, a hematologist-oncologist who specializes in the treatment of blood cancers may utilize a patient’s medical history to perform subtype testing, in order to help determine the specific type of sAML and inform treatment decisions.

The Progression of MDS to AML

About one-third of people diagnosed with myelodysplastic syndromes (MDS) may develop secondary acute myeloid leukemia (sAML).4 Here’s what you need to know about the possibility of developing sAML.

The Role of a Caregiver

Like so many other diseases, cancer does not just impact the patient. In many scenarios, there are partners, siblings, children and/or friends who take on the role of caregiver.